Makary for FDA. Here’s what you need to know.
President-elect Donald Trump’s Friday night news dump of health care nominees included the expected naming of Dr. Marty ...
STAT6d
Trump’s pick to run FDA is top exec of company that provides compounded weight-loss drugs
Martin Makary, President-elect Trump’s pick for running the Food and Drug Administration, is an executive of the telehealth ...
denver74d
FDA warns consumers about risks of unapproved versions of weight loss drugs
The Federal Drug Administration (FDA) is warning consumers about unapproved semaglutide, a popular weight loss drug ...
Exclusive: US FDA finds widely used asthma drug impacts the brain
U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co may be linked to ...
NBC Los Angeles on MSN12d
FDA weighs in on diet drug shortage, creating more confusion about compounding
As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.
WebMD5d
FDA Approves New Drug for Life-Threatening Heart Condition
The FDA has approved Attruby, a new oral treatment that helps reduce heart-related deaths and hospital visits among adults ...
Gottlieb: RFK Jr. ‘will cost lives’ if he follows through on health plans
Scott Gottlieb, who served as commissioner of the Food and Drug Administration (FDA) during President-elect Trump’s first ...
Applied Therapeutics: FDA Issues CRL For New Drug Application For Govorestat - Quick Facts
Applied Therapeutics (APLT) announced the FDA has issued a Complete Response Letter for the New Drug Application for govorestat, for ...
US FDA declines to approve Applied Therapeutics' genetic disease drug
Applied Therapeutics said on Wednesday that the U.S. FDA declined to approve its drug to treat galactosemia, a rare genetic ...
FDA gives green light to PTSD marijuana study in veterans
The Food and Drug Administration (FDA) this week authorized a long-delayed clinical trial to test whether smoking marijuana ...
FDA to Review Exelixis' Application to Expand Use of Cancer Drug
Exelixis plans to meet with the FDA's oncologic drugs advisory committee in March to discuss the drug's potential new uses. The meeting will review the safety and effectiveness of the cancer drug ...